TMDX

TransMedics Group
TMDX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$4.45B
EV
$4.66B
Shares Outstanding
37.18M
Beta
2.05

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$135.86
P/E 2025E
73.36x
P/Revenue 2025E
7.67x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About TransMedics Group, Inc.

gainify
TMDX

TransMedics Group, Inc.

TMDX

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusi...

Sector

Healthcare

Industry

Medical - Devices

CEO

Hassanein, Waleed

Employees

728

IPO Date

2019-05-02

Headquarters

200 Minuteman Road, Suite 302, Andover, Massachusetts, 01810, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.